Modulators of protein secretion
Patent Information
- Application Number
- HK62026123969
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-11
- Filing Date
- 2026-05-26
- Publication Date
- 2026-09-11
Smart Images

Figure 00000030_0000 
Figure 00000031_0000 
Figure 00000031_0001
Abstract
Description
Abstract This disclosure provides a method for identifying protein secretion regulators. It also provides protein secretion regulators and their uses.
Claims
CLAIMS1. A method of inhibiting protein secretion from a eukaryotic cell, comprising contacting the cell with nigericin or tyrphostin AG-879, or an analog thereof.
2. The method of claim 1, wherein the cell is in a cell culture.
3. The method of claim 2, wherein the contacting comprises adding nigericin, tyrphostin AG-879, or analog to the cell culture.
4. The method of claim 3, wherein the nigericin, tyrphostin AG0879, or analog is added to the cell culture to reach a concentration of about 1 pg / mL to about 100 pg / mL, optionally about 5 pg / mL to about 50 pg / mL.
5. The method of claim 3, wherein the nigericin, tyrphostin AG0879, or analog is added to the cell culture to reach a concentration of at least about 50 pg / mL; optionally, wherein the nigericin, tyrphostin AG0879, or analog is added to the cell culture to reach a concentration of about 50 pg / mL.
6. A method of increasing protein secretion from a eukaryotic cell, comprising contacting the cell with lycorine or an analog thereof.
7. The method of claim 5, wherein the eukaryotic cell is a recombinant cell engineered to express a recombinant protein.
8. The method of claim 6, wherein the recombinant protein is an enzyme for enzyme replacement therapy, or an antibody.
9. The method of any one of claims 5-7, wherein the cell is in a cell culture.
10. The method of claim 8, wherein the contacting comprises adding lycorine or analog to the cell culture.
11. The method of claim 9, wherein the lycorine or analog is added to the cell culture toreach a concentration of about 0.1 pM to about 100 pM, optionally about 1 pM to about 50 pM.
12. The method of claim 9, wherein the lycorine or analog is added to the cell culture to reach a concentration of at least about 1 pM.
13. The method of claim 9, wherein the lycorine or analog is added to the cell culture to reach a concentration of about 1 pM or of about 50 pM.
14. The method of any one of the preceding claims, wherein the eukaryotic cell is a mammalian cell, an insect cell, or a yeast cell.
15. The method of claim 11, wherein the cell is a mammalian cell, optionally a CHO cell, a NS0 cell, a BHK cell, a 293 cell, a HeLa cell, a HEK cell, or a Sp2 / 0 cell.
